Table I.
FDA approved drugs in HIV therapy (drugs with abbreviations are referred to as such in the article).
| Drug | Brand name | Manufacturer |
|---|---|---|
| Nucleoside reverse transcriptase inhibitors (NRTIs) | ||
| Zidovudine (AZT) | Retrovir | GlaxoSmithKline |
| Didanosine (ddI) | Videx | Bristol Myers-Squibb |
| Zalcitabine (ddC) | Hivid | Hoffmann-La Roche |
| Stavudine (d4T) | Zerit | Bristol Myers-Squibb |
| Lamivudine (3TC) | Epivir and Zeffix | GlaxoSmithKline |
| Abacavir sulfate (ABC) | Ziagen | GlaxoSmithKline |
| Emtricitabine (FTC) | Emtriva | Gilead Sciences, Inc. |
| Nucleotide reverse transcriptase inhibitors (NtRTIs) | ||
| Tenofovir disoproxil fumarate | Viread | Gilead Sciences, Inc. |
| Non-nucleoside reverse transcriptase inhibitors (NNRTIs) | ||
| Nevirapine (NVP) | Viramune | Boehringer Ingelheim |
| Delavirdine (DLV) | Rescriptor | Pfizer |
| Efavirenz (EFV) | Sustiva and Stocrin | Bristol Myers-Squibb |
| Entavirine (TMC125) | Intelence | Tibotec, Inc. |
| Protease inhibitors (PIs) | ||
| Saquinavir mesylate (SQV) | Invirase and Fortovase | Hoffmann-La Roche |
| Ritonavir | Norvir | Abott Laboratories |
| Indinavir (IND) | Crixivan | Merck & Co., Inc. |
| Nelfinavir mesylate (NFV) | Viracept | Agouron Phramaceuticals |
| Amprenavir | Agenerase and Prozei | GlaxoSmithKline |
| Fosamprenavir calcium (Prodrug of amprenavir) | Lexiva and Telzir | GlaxoSmithKline |
| Atazanavir sulfate | Reyataz | Bristol Myers-Squibb |
| Lopinavir and ritonavir | Kaletra | Abott Laboratories |
| Tipranavir | Aptivus | Boehringer Ingelheim |
| Darunavir | Prezista | Tibotec, Inc. |
| Entry and fusion inhibitors | ||
| Maraviroc | Salzentry | Pfizer |
| Enfuvirtide | Fuzeon | Hoffmann-La Roche, Trimeris |
| Integrase inhibitors | ||
| Raltegravir | Isentress | Merck & Co., Inc. |